n-Fmoc-5,5-dimethyl-L-norleucine is a sterically enhanced aliphatic amino acid featuring terminal dimethyl substitution. The added bulk influences backbone orientation and hydrophobic packing in synthetic peptides. Researchers employ it to study steric constraints, helix modulation, and solvent-dependent conformations. Its Fmoc protection supports compatibility with standard solid-phase methods.
CAT No: R2141
CAS No:1217704-60-3
Synonyms/Alias:n-fmoc-5,5-dimethyl-l-norleucine;1217704-60-3;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5,5-dimethylhexanoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5,5-dimethylhexanoic acid;MFCD30533759;CS-0104683;D76435;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5,5-dimethylhexanoic acid;
n-Fmoc-5,5-dimethyl-l-norleucine is a synthetic amino acid derivative characterized by the presence of an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group and a structurally unique, sterically hindered side chain. This compound is particularly valued in the field of peptide chemistry, where its distinctive dimethyl-substituted norleucine backbone imparts both conformational rigidity and enhanced hydrophobicity. Researchers utilize such non-canonical amino acids to explore peptide structure-activity relationships, modulate peptide folding, and introduce specific steric or electronic effects into synthetic sequences. The Fmoc group facilitates its integration into solid-phase peptide synthesis (SPPS) workflows, making it a versatile building block for advanced peptide engineering and biochemical studies.
Peptide Synthesis: n-Fmoc-5,5-dimethyl-l-norleucine is primarily employed as a protected amino acid monomer in solid-phase peptide synthesis. Its Fmoc group allows for orthogonal deprotection under mild basic conditions, enabling stepwise assembly of peptides containing this sterically demanding residue. The incorporation of the dimethyl-norleucine moiety can be strategically used to introduce conformational constraints, enhance resistance to enzymatic degradation, or modulate the hydrophobic character of synthetic peptides. This makes it a valuable tool for constructing custom peptide libraries and investigating the impact of side chain modifications on biological function.
Structure-Activity Relationship Studies: The unique steric and hydrophobic properties of 5,5-dimethyl-l-norleucine are leveraged by researchers to probe the influence of side chain bulk on peptide structure and activity. By substituting this residue at specific positions within bioactive peptides, scientists can assess changes in receptor binding, conformational stability, or aggregation propensity. Such studies are critical for the rational design of peptide analogs with improved selectivity, potency, or biophysical properties, thereby advancing fundamental understanding of peptide-protein interactions and molecular recognition processes.
Peptidomimetic Design: The incorporation of non-standard amino acids like 5,5-dimethyl-l-norleucine is a powerful strategy in the development of peptidomimetics—molecules that mimic the structure and function of natural peptides while exhibiting enhanced metabolic stability or altered biological profiles. Its steric bulk can disrupt protease recognition sites or stabilize specific secondary structures, such as α-helices or β-turns, within synthetic analogs. This enables the creation of peptide-based tools and probes for biochemical research, target validation, and mechanism-of-action studies in a controlled laboratory setting.
Combinatorial Library Generation: The use of Fmoc-protected, sterically modified amino acids facilitates the creation of diverse combinatorial peptide libraries for high-throughput screening applications. By incorporating n-Fmoc-5,5-dimethyl-l-norleucine into library designs, researchers can systematically explore the effects of side chain variations on peptide function, binding affinity, or physicochemical properties. Such libraries are instrumental in identifying novel ligands, optimizing lead compounds, or mapping sequence-activity landscapes for various biological targets.
Protein Engineering and Folding Studies: The unique side chain of 5,5-dimethyl-l-norleucine offers opportunities to investigate the role of hydrophobic packing and steric effects in protein folding and stability. Incorporation of this residue into model peptides or protein fragments enables detailed analysis of folding pathways, core packing interactions, and the influence of side chain modifications on tertiary structure formation. These studies contribute to a deeper understanding of protein architecture and inform the rational engineering of proteins with tailored properties for research and industrial applications.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Emu oil in combination with other active ingredients for treating skin imperfections
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More